BioCentury | Oct 3, 2019
Emerging Company Profile

X-Vax: Bucking dogma in HSV vaccine development

...a vector to deliver antigens associated with other pathogens such as flu, tuberculosis and HIV. Xenova Group plc...
BioCentury | Apr 12, 2010
Company News

Cytos, Independent Pharmaceutica, Nabi, Novartis, Celtic Pharma neurology news

...opposition brought by Nabi, Cytos, Novartis and Independent Pharmaceutica, the European Patent Office (EPO) revoked Xenova Group plc...
...application, because nicotine was not singled out in the parent application. Celtic Pharma, which acquired Xenova...
BioCentury | Jan 26, 2010
Financial News

Cantab gets L5 million from Celtic Pharma

...Cantab, then called Cambridge Biomanufacturing Ltd., last year. In 2007, Cambridge Biomanufacturing spun out of Xenova Group plc...
BioCentury | Dec 14, 2009
Finance

Ebb & Flow

...to assets emerging from Imperial College London . Louis Nisbet, former founder and CEO of Xenova...
BioCentury | Feb 12, 2007
Clinical News

TransMID: Development discontinued

...Sosei in Japan; Nycomed in Europe; Ranbaxy in India; and Medison in Israel. Celtic subsidiary Xenova...
BioCentury | Feb 8, 2007
Financial News

Celtic raises $156 million, drops TransMID

...in Europe; Ranbaxy (NSE:RANBAXY) in India; and Medison (Petach Tikva, Israel) for Israel. Celtic subsidiary Xenova...
BioCentury | Sep 25, 2006
Strategy

Nycomed-Altana pipeline

...contrast agent Cardiology Ph III Acusphere TransMID Diphtheria toxin conjugated to transferrin Oncology Ph III Xenova...
BioCentury | Jul 24, 2006
Company News

BioAnaLab Ltd. board of directors update

...BioAnaLab Ltd. , Oxford, U.K. Business: Supply/Service Appointed: David Oxlade, former CEO of Xenova Group plc , as...
BioCentury | Jul 3, 2006
Company News

Cobra Bio board of directors update

...Cobra Biomanufacturing plc (LSE:CBF), Keele, U.K. Business: Biomanufacturing, Supply/Service Appointed: David Oxlade, former CEO of Xenova Group plc...
BioCentury | Oct 3, 2005
Finance

Tracking QLT

...by 18% to 296 from 361 to focus on Visudyne.D. 2/21/03 - QLT and partner Xenova...
...safety monitoring committee (DSMC) recommended the action because of safety concerns.E. 5/12/03 - QLT and Xenova...
Items per page:
1 - 10 of 292
BioCentury | Oct 3, 2019
Emerging Company Profile

X-Vax: Bucking dogma in HSV vaccine development

...a vector to deliver antigens associated with other pathogens such as flu, tuberculosis and HIV. Xenova Group plc...
BioCentury | Apr 12, 2010
Company News

Cytos, Independent Pharmaceutica, Nabi, Novartis, Celtic Pharma neurology news

...opposition brought by Nabi, Cytos, Novartis and Independent Pharmaceutica, the European Patent Office (EPO) revoked Xenova Group plc...
...application, because nicotine was not singled out in the parent application. Celtic Pharma, which acquired Xenova...
BioCentury | Jan 26, 2010
Financial News

Cantab gets L5 million from Celtic Pharma

...Cantab, then called Cambridge Biomanufacturing Ltd., last year. In 2007, Cambridge Biomanufacturing spun out of Xenova Group plc...
BioCentury | Dec 14, 2009
Finance

Ebb & Flow

...to assets emerging from Imperial College London . Louis Nisbet, former founder and CEO of Xenova...
BioCentury | Feb 12, 2007
Clinical News

TransMID: Development discontinued

...Sosei in Japan; Nycomed in Europe; Ranbaxy in India; and Medison in Israel. Celtic subsidiary Xenova...
BioCentury | Feb 8, 2007
Financial News

Celtic raises $156 million, drops TransMID

...in Europe; Ranbaxy (NSE:RANBAXY) in India; and Medison (Petach Tikva, Israel) for Israel. Celtic subsidiary Xenova...
BioCentury | Sep 25, 2006
Strategy

Nycomed-Altana pipeline

...contrast agent Cardiology Ph III Acusphere TransMID Diphtheria toxin conjugated to transferrin Oncology Ph III Xenova...
BioCentury | Jul 24, 2006
Company News

BioAnaLab Ltd. board of directors update

...BioAnaLab Ltd. , Oxford, U.K. Business: Supply/Service Appointed: David Oxlade, former CEO of Xenova Group plc , as...
BioCentury | Jul 3, 2006
Company News

Cobra Bio board of directors update

...Cobra Biomanufacturing plc (LSE:CBF), Keele, U.K. Business: Biomanufacturing, Supply/Service Appointed: David Oxlade, former CEO of Xenova Group plc...
BioCentury | Oct 3, 2005
Finance

Tracking QLT

...by 18% to 296 from 361 to focus on Visudyne.D. 2/21/03 - QLT and partner Xenova...
...safety monitoring committee (DSMC) recommended the action because of safety concerns.E. 5/12/03 - QLT and Xenova...
Items per page:
1 - 10 of 292